Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc. > Analyst sentiment seems favourable overall

<< Previous

Bullboard Posts

Next >>

Post by OneBigFishon Dec 17, 2020 2:03pm

323 Views

Post# 32129649

Analyst sentiment seems favourable overall

Like any merger the new company will have to show results.

Aphria Inc Price Target Raised to C$12.00/Share From C$9.00 by Alliance Global Partners (Buy maintained)

Aphria Inc. Price Target Is Maintained at C$11.00/Share by PI Financial (Buy maintained)

Aphria Inc Price Target Raised to C$9.80/Share From C$8.25 by Stifel Nicolaus (downgrade to Hold)

CIBC World Markets analyst John Zamparo raised his target to $12.50 from $9 (Outperform, buy maintained)

Cannacord maintained C$11.00/Share (downgrade to hold)

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks